InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60
United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

22
Insider
Date
Role
Action
Shares
Price
Amount
Najat Khan
18 Aug 2025
Chief R&D Commercial Officer
Sell
36,599
$5.52
$202.17K
Blake Borgeson
14 Nov 2023
Director
Sell
8,885
$6.32
$56.15K
Blake Borgeson
31 Oct 2023
Director
Sell
8,885
$5.27
$46.86K
Blake Borgeson
17 Oct 2023
Director
Sell
8,885
$6.58
$58.48K
Blake Borgeson
3 Oct 2023
Director
Sell
8,885
$7.29
$64.78K
Blake Borgeson
19 Sep 2023
Director
Sell
8,885
$8.36
$74.28K
Blake Borgeson
5 Sep 2023
Director
Sell
8,885
$8.79
$78.14K
Blake Borgeson
22 Aug 2023
Director
Sell
8,885
$8.91
$79.18K
Blake Borgeson
8 Aug 2023
Director
Sell
3,272
$11.75
$38.44K
Blake Borgeson
8 Aug 2023
Director
Sell
14,498
$11.03
$159.85K
Blake Borgeson
25 Jul 2023
Director
Sell
18,719
$14.61
$273.46K
Terry-Ann Burrell
13 Jul 2023
Director
Sell
8,275
$12.59
$104.14K
Terry-Ann Burrell
12 Jul 2023
Director
Sell
3,157
$14.08
$44.46K
Terry-Ann Burrell
12 Jul 2023
Director
Sell
3,195
$13.18
$42.12K
Terry-Ann Burrell
12 Jul 2023
Director
Sell
78,071
$12.15
$948.29K
Terry-Ann Burrell
12 Jul 2023
Director
Sell
24,302
$11.25
$273.40K
Blake Borgeson
11 Jul 2023
Director
Sell
8,885
$6.89
$61.19K
Blake Borgeson
27 Jun 2023
Director
Sell
8,885
$7.39
$65.64K
Blake Borgeson
13 Jun 2023
Director
Sell
15,485
$9.98
$154.51K
Blake Borgeson
30 May 2023
Director
Sell
8,885
$8.79
$78.13K
Blake Borgeson
16 May 2023
Director
Sell
8,885
$5.09
$45.24K
Blake Borgeson
18 Apr 2023
Director
Sell
8,885
$5.93
$52.73K
Showing 250 of 464 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 479
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 57
Sales straight out of an exercise 308
Sales at will 56
Transactions with no price 0
Shares from compensation/vesting 217,995,789
Sales filed before the plan box existed 31
History held since 19 Apr 2021